Zaha Hisamitsu, Abe Norie, Sagawa Noriko, Unesoko Mikiko
Department of Breast Surgery, Nakagami Hospital, 610 Noborikawa, Okinawa-city, Okinawa, Japan.
Breast Cancer Res Treat. 2017 Apr;162(2):267-274. doi: 10.1007/s10549-017-4124-9. Epub 2017 Jan 24.
There are several small case series on use of a laparoscopically harvested omental flap (LHOF) for breast reconstruction. However, the long-term oncological safety and clinical benefits of the LHOF remain uncertain, especially in use of the flap in oncoplastic breast surgery.
A retrospective chart review was performed for 200 patients who underwent oncoplastic breast surgery using a LHOF at our institution from April 2002 to March 2016. Laparoscopy-associated complications, local recurrence, and cosmetic outcomes were evaluated.
Most of the patients underwent partial breast reconstruction immediately after breast-conserving surgery (BCS). The success rate of laparoscopic harvesting of the omental flap was 99.5%. The rate of complications was 12.0% and laparoscopy-associated complications occurred in four cases (2.0%). The rate of a positive margin was 6.5%. Two cases (1.0%) had local recurrence during a median follow-up period of 90 months. In 24 patients (12.0%), the volume of the flap was insufficient. When applied to total reconstruction, volume insufficiency occurred in 32.6% of patients. Cosmetic outcomes were mostly satisfactory. Approximately 80% of patients were rated as good or excellent by evaluation using a 4-point scale and Breast Cancer Conservative Treatment cosmetic results (BCCT.core) software. Donor-site scars were negligible, as in laparoscopic cholecystectomy.
The LHOF has minimal donor-site morbidity and deformity, and oncological safety is promising. There is a limit to the adaptable volume, but the LHOF is an attractive option in partial breast reconstruction after BCS.
有几个关于使用腹腔镜获取网膜瓣(LHOF)进行乳房重建的小病例系列报道。然而,LHOF的长期肿瘤学安全性和临床益处仍不确定,尤其是在肿瘤整形乳房手术中使用该皮瓣时。
对2002年4月至2016年3月在我院接受使用LHOF进行肿瘤整形乳房手术的200例患者进行回顾性病历审查。评估了腹腔镜相关并发症、局部复发和美容效果。
大多数患者在保乳手术(BCS)后立即进行了部分乳房重建。网膜瓣腹腔镜获取的成功率为99.5%。并发症发生率为12.0%,腹腔镜相关并发症发生4例(2.0%)。切缘阳性率为6.5%。在中位随访期90个月期间,2例(1.0%)出现局部复发。24例患者(12.0%)皮瓣体积不足。当应用于全乳房重建时,32.6%的患者出现体积不足。美容效果大多令人满意。使用4分制评估和乳腺癌保守治疗美容结果(BCCT.core)软件,约80%的患者被评为良好或优秀。供区疤痕可忽略不计,如同腹腔镜胆囊切除术。
LHOF供区发病率和畸形最小,肿瘤学安全性良好。可适应的体积有限,但LHOF是BCS后部分乳房重建中一个有吸引力的选择。